SNTI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Senti Biosciences, Inc (SNTI) is not a strong buy for a long-term beginner investor at this moment. The stock lacks significant positive catalysts, has no recent trading signals, and its financials, while showing improvement in net income and EPS, remain negative. Additionally, there is no strong trading sentiment or news to support a bullish outlook. A hold is recommended until more favorable conditions arise.
The technical indicators are neutral. The MACD is above 0 but contracting positively, RSI is at 49.143 (neutral zone), and moving averages are converging. The stock is trading near its pivot level of 1.022, with resistance at 1.153 and support at 0.892. There is no clear bullish or bearish trend.
The company's net income and EPS have shown significant YoY improvement, with net income up 2271.64% and EPS up 307.69%.
No significant trading trends from hedge funds or insiders. No news or event-driven catalysts in the recent week. The financials, while improving, still show a net loss. No recent congress trading data.
In Q4 2025, revenue remained flat YoY at 22,000. Net income improved significantly YoY but remains negative at -14,467,000. EPS improved to -0.53, and gross margin remained at 100%.
No recent analyst ratings or price target changes available.
